Stay updated on SRP-4045 Dose-Titration in DMD: Clinical Trial

Sign up to get notified when there's something new on the SRP-4045 Dose-Titration in DMD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SRP-4045 Dose-Titration in DMD: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:24:59.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study record related to a first-in-human dose-titration and open-label extension study for advanced-stage Duchenne muscular dystrophy patients with deletions amenable to exon 45 skipping.
    Difference
    0.2%
    Check dated 2024-06-06T14:24:33.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study. The new criteria specify that participants must have genotypically confirmed DMD amenable to exon 45 skipping, stable cardiac and pulmonary function, limited or no ambulation, and be on a stable dose of oral corticosteroids.
    Difference
    13%
    Check dated 2024-05-22T20:29:12.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:04.000Z thumbnail image

Stay in the know with updates to SRP-4045 Dose-Titration in DMD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SRP-4045 Dose-Titration in DMD: Clinical Trial page.